Document is current
Any future updates will be listed below
-
Authors
Sano, Tatsuhiko http://orcid.org/0000-0002-2992-9150
Nagata, Tetsuya http://orcid.org/0000-0003-4111-2693
Ebihara, Satoe
Yoshida-Tanaka, Kie
Nakamura, Ayako
Sasaki, Asuka
Shimozawa, Aki
Mochizuki, Hideki
Uchihara, Toshiki
Hasegawa, Masato
Yokota, Takanori http://orcid.org/0000-0002-6490-3263
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18am0301003h0005, 23am0401006h0005)
Japan Society for the Promotion of Science (22H00440, 16H05221)
- License Information
-
More Information
Article History
Received: 21 March 2024
Accepted: 26 March 2024
First Online: 14 May 2024
Declarations
:
: All experimental protocols were approved by the Institutional Animal Care and Use Committee of Tokyo Medical and Dental University (Approval Number A2022-085A).
: T.Y. has ongoing collaborations with Takeda Pharmaceutical Co., Ltd. and serves as an academic advisor for Rena Therapeutics Inc. and Nissan Chemical Corporation. The other authors declare no competing interests.
